India: NMC Delays MBBS Seat Cap Decision Amid State Opposition, and More

Dear Dr. Renukaprasad A R, Top Stories of the Day: 1. NMC Delays MBBS Seat Cap Decision Amid State Opposition 2. World-first gene therapy for Sickle Cell Disease & Transfusion-dependent β-thalassemia 3. USFDA Authorization for First Home-based Test for Chlamydia and Gonorrhea 4. Studies Forecast Kidney Failure Patients in Malaysia to Double by 2040 Watch News Docplexus: One of the world's largest online communities of Doctors Pune - 411045, India Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Diabetes Management: CGM & Gut Microbiome

Dear Dr. Renukaprasad A R, Latest diabetes technologies, such as continuous glucose monitoring (CGM) systems and automated insulin delivery devices, have improved diabetes management tremendously in the past few years. By helping make efficient treatment decisions and delivering precise amounts of insulin, these technologies have started a new era of managing diabetes. Gut microbiota dysbiosis has been observed in patients with obesity, type 2 diabetes, and inflammatory bowel diseases. The relationship between the gut microbiota and diabetes has been studied extensively to improve diabetes treatment. To gain detailed insights into continuous glucose monitoring systems and gut microbiome in diabesity, join the eminent Diabetologists Dr. Kavitha Bhat and Dr. Usha Sriram in our Global Diabetes Summit special webinar, TODAY, 6:00 PM IST onwards. Topics - New Trends in Diabetes Management: Continuous Glucose Monitoring – Dr. Kavitha Bhat Gut Microbiome in Diabesity – Dr. Usha Sriram Join Now Docplexus: One of the world's largest online communities of Doctors Pune - 411045, India info@docplexus.co.in   |  +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Comprehensive Discussions on GLP-1 RAs and SGLT2 Inhibitors

Dear Dr. Renukaprasad A R, Although GLP-1 RAs and SGLT2 inhibitors reduce glucose levels, body weight, and the risk of diabetes-related complications, they have differences in providing benefits and causing adverse events. Therefore, diabetologists must be aware of their characteristics before prescribing them to their patients. Unlike other GLP-1 RAs, semaglutide has a longer half-life and can be administered subcutaneously or orally. Compared to other GLP-1 RAs, semaglutide is found to cause no major adverse events except for increasing cholelithiasis risk and causing mild gastrointestinal disturbances. However, several clinical trials are going on to improve the use of semaglutide. To make your diabetes management strategy efficient with GLP-1 RAs and SGLT2 inhibitors, we exclusively bring you a special Global Diabetes Summit 2023 session by leading Diabetologists Dr. Kathija Mahmood and Dr. Supratik Bhattacharya TODAY from 3:00 PM IST onwards. Topics - Assessing the Comparative Effectiveness of GLP-1 Receptor Agonists vs. SGLT2 Inhibitors in Type 2 Diabetes – Dr. Kathija Mahmood Efficacy and Safety of Semaglutide in Type 2 Diabetes – Dr. Supratik Bhattacharya Join Now Docplexus: One of the world's largest online communities of Doctors Pune - 411045, India info@docplexus.co.in   |  +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

India Bolsters Healthcare Services to Tackle Air Pollution-related Ailments, and More

Dear Dr. Renukaprasad A R, Top Stories of the Day: 1. India Bolsters Healthcare Services to Tackle Air Pollution-related Ailments 2. USFDA Approves Tirzepatide for Chronic Weight Management 3. Blocking IL-6R Prevents Preterm Birth and Adverse Neonatal Outcomes 4. WHO Evacuates Pediatric Cancer Patients from Gaza Watch News Docplexus: One of the world's largest online communities of Doctors Pune - 411045, India Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Mucins Revisited: Rediscovering Their Importance in Ocular Health

Dear Dr. Renukaprasad A R, Mucins are pivotal in maintaining tear film quality and ocular health. Alterations in mucin expression or function contribute to ocular surface diseases and dry eye disease (DED). Explore our informative infographic that emphasizes the critical role of mucins in preserving ocular health and their direct link to DED. Click to Read Docplexus: One of the world's largest online communities of Doctors Pune - 411045, India info@docplexus.co.in   |  +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

The New Era of Diabeto-oncology

Dear Dr. Renukaprasad A R, Concomitant increases in the risks of diabetes and cancer are linked to several factors that are common between the two conditions.  While hyperglycemia and hyperinsulinemia increase the risk of cancer in people with diabetes, sarcopenia, stress, steroid use, and tumor-related cytokines make cancer patients more prone to diabetes. To learn more about the relationship between diabetes and cancer, join the reputed team of experts in a case-based discussion in our exclusive Global Diabetes Summit session, TODAY, 6:00 PM IST onwards. Click to Join Docplexus: One of the world's largest online communities of Doctors Pune - 411045, India info@docplexus.co.in   |  +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*